ONTEX GROUP NV REGULATED INFORMATION
Ontex announces Q3 2020 results;
Strategic review and cost reduction plans underway
to step up performance and value creation
Aalst-Erembodegem, November 4, 2020 - Ontex Group NV (Euronext Brussels: ONTEX; 'Ontex,' 'the
Group' or 'the Company') today announced its results for the three months and nine months ending September 30, 2020.
- Reported revenue: €508 million (-12% vs. Q3 2019) including a €43 million negative currency impact; -4.6%like-for-like (LFL) on the back of lower personal hygiene market demand and increased competition
- Adjusted EBITDA: €57 million (-€4 million vs. Q3 2019) including a €17 million negative currency impact; Adjusted EBITDA margin of 11.3% (+57 bps vs. Q3 2019), benefiting from further gains from T2G and lower raw material indices
- Actions underway to restore growth and profitability
-
Launch of in-depth strategic review and creation of Strategy Committee o Intensified T2G efforts to secure operational and commercial gains
o Additional plan to reduce overhead costs by €11 million on a full-year basis o Cut in 2020 management variable compensation pool
Strategic review underway to step up performance and value creation
Following recent leadership changes, including the appointment in May of Hans van Bylen as new Chairman of the Board and in July of Thierry Navarre as interim CEO, the Board of Directors has decided to create a Strategy Committee, tasked with re-shaping the company's strategic priorities and expediting decision- making and execution. A strategic review launched in late August is currently underway, covering the following aspects:
- Accelerating delivery of operational efficiencies through intensified T2G efforts
- Reviewing the company's cost structure
- First decision to reduce overhead costs by €11 million on a full-year basis with first savings starting in Q4 2020
- Strengthening commercial capabilities in an increasingly competitive marketplace
- Re-assessingOntex's strategic intent for each geography, category, channel and brand
- Right-sizingthe operational footprint in line with strategic choices and level of activity
- Evaluating external growth opportunities with strict financial discipline
The outcome of this review will be a strengthened business model, reflecting clear choices on where to play and how to win, and measurable targets to follow progress in implementation. Capital will be allocated in alignment with key priorities, and the remuneration policy is being revised to tie management compensation more closely with company performance.
1
REGULATED INFORMATION
Thierry Navarre, Ontex CEO, commented: "Ontex posted a sequential improvement in sales in Q3 in the face of the unprecedented market conditions resulting from the COVID-19 pandemic, and profitability benefited from ongoing T2G-driven gains. However, even allowing for these market conditions, we are not satisfied with the current level of performance and recognize that it must be stepped up. Therefore, Ontex's Board of Directors and Management are mobilizing all Ontex resources to take further decisive actions. This encompasses a wide range of initiatives, including a full strategic review with no taboos, as well as first decisions to reduce overhead costs across the Group and a cut in management's short-term variable compensation pool for this year. We are fully committed to making the necessary changes in order to address our challenges and return to sustainable top- and bottom-line growth and value creation."
Key Financials for 9M 2020 and Q3 2020
Nine Months | Third Quarter | ||||||||||||||||||||||||
€ in million, except per | 2020 | 2019 | % Change | 2020 | 2019 | % Change | |||||||||||||||||||
share data | |||||||||||||||||||||||||
Reported Revenue | 1,561.3 | 1,688.7 | -7.5% | 507.9 | 574.4 | -11.6% | |||||||||||||||||||
LFL Revenue | 1,639.9 | 1,688.7 | -2.9% | 548.2 | 574.4 | -4.6% | |||||||||||||||||||
Adjusted EBITDA | 183.1 | 172.4 | +6.2% | 57.1 | 61.4 | -6.9% | |||||||||||||||||||
Adj. EBITDA Margin | 11.7% | 10.2% | +152 bps | 11.3% | 10.7% | +57 bps | |||||||||||||||||||
Adjusted EBITDA at constant | 231.8 | 172.4 | +34.5% | 74.1 | 61.4 | +20.7% | |||||||||||||||||||
currencies | |||||||||||||||||||||||||
Adjusted EBITDA Margin at | 14.1% | 10.2% | +390 bps | 13.4% | 10.7% | +272 bps | |||||||||||||||||||
constant currencies | |||||||||||||||||||||||||
Nine Months | |||||||||||||||||||||||||
in € million, except per | 2020 | 2019 | % Change | ||||||||||||||||||||||
share data | |||||||||||||||||||||||||
Net Debt | 877.6 | 875.7 | +0.2% | ||||||||||||||||||||||
Net Debt / LTM Adj. | 3.43x | 3.68x | -0.25x | ||||||||||||||||||||||
EBITDA | |||||||||||||||||||||||||
N.M.: not meaningful
Notes which apply to this document
Unless otherwise indicated, all comments in this document on changes in revenue are on a like-for-like basis (at constant currencies). Definitions of Alternative Performance Measures (APMs) in this document can be found under the section Corporate Information.
Due to rounding, numbers presented throughout this press release may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.
Net debt
Net debt was €877.6 million at September 30, 2020, in line with September 30, 2019. Leverage stood at 3.43x at September 30, 2020, lower than the 3.68x at September 30, 2019, and marginally below 3.51x at December 31, 2019.
Decision on dividend in 2020
On April 9, 2020 the Company disclosed in an ad-hoc update on activity and COVID-19 impact that the Board of Directors had decided not to propose paying a dividend to the General Meeting in May to preserve cash resources and financial flexibility, and pledged to revisit the possible payment of a dividend later in the year. The Board of Directors has now decided that it would not be appropriate to pay a dividend in 2020 in light of ongoing uncertainties related to the pandemic and continued focus on cash preservation.
Planned retirement of CFO; succession process underway
Charles Desmartis, CFO, has communicated his intention to retire, effective March 31, 2021. A search for his successor is underway.
2
REGULATED INFORMATION
Transform to Grow (T2G) Progress Report
We have generated €57 million of T2G-related gross gains to Adjusted EBITDA at constant currencies in the first nine months of 2020.
After nine months we continue to be ahead of our targets in procurement, excluding any benefit from lower raw material indices. The delivery of our efficiency and cost improvement ambitions in manufacturing and supply chain is progressing but requires a further enhancement of our skills, processes and systems, and thus is taking more time than initially anticipated. The commercial workstreams are not yet delivering the expected benefits to date, in an environment characterized by increased volatility and lower demand.
The pandemic and related measures taken to combat it have impeded progress of initiatives in both the operational and commercial workstreams since March 2020. All efforts are being made to overcome these obstacles and capture the targeted benefits.
Q3 2020 Highlights
Q3 2020 reported revenue of €508 millon marked a €29 million improvement versus Q2 2020, with demand slowly recovering following the initial pandemic-related demand surge and subsequent decrease in H1. Furthermore, the depreciation of currencies versus the euro resulted in a negative currency impact of €43 million on Q3 sales, resulting in a decrease in reported revenue of -11.6%year-on-year.
Q3 2020 Adjusted EBITDA was €57.1 million, including a €17 million unfavorable impact of currency movements compared with Q3 2019. The year-on-year improvement at constant currencies was supported by T2G-driven gains and lower raw material indices. The Board has approved Management's proposal of a significant cut in the 2020 short-term variable compensation pool, taking into account the expected FY 2020 performance reflecting unprecedented negative currency effects and lower activity. This has resulted in a one-time adjustment of +€4 million to Q3 Adjusted EBITDA. COVID-19 related costs for an amount of -€3 million were incurred in Q3 2020 (YTD 2020: -€11 million) and recognized as recurring expenses in the income statement.
2020 outlook
Ontex continues to operate in a highly uncertain environment across its markets due to the evolution of the pandemic, which has been undermining currencies of emerging countries, disrupting consumer demand and purchasing behavior and resulting in increased competition as industry players face sales contraction in traditional channels.
In such an environment, FY Group LFL revenue variation could be expected to be broadly similar to 9M 2020. However, the resurgence of the pandemic in many geographies, including Europe, has already triggered new lockdown measures whose impact on sales in the final 2 months of 2020 is difficult to predict.
The positive impacts from further improvement of T2G workstreams, raw material indices and the first effects of overhead cost reduction measures on operating profitability will largely be offset by higher price investments and lower operating leverage on the back of lower volumes.
The effects of currency movements in Q4 on both revenue and Adjusted EBITDA are expected to be the highest of the year.
3
REGULATED INFORMATION
Operational Review: Categories
Nine Months | |||||||||||||||
in € million | 2020 | 2019 | % ∆ as | % ∆ at | |||||||||||
reported | LFL | ||||||||||||||
Ontex Reported Revenue | 1,561.3 | 1,688.7 | -7.5% | -2.9% | |||||||||||
Babycare | 871.8 | 989.8 | -11.9% | -6.3% | |||||||||||
Adult Incontinence | 503.7 | 517.1 | -2.6% | +1.5% | |||||||||||
Femcare | 162.3 | 159.5 | +1.7% | +1.3% | |||||||||||
Other | 23.5 | 22.3 | +5.4% | +15.8% | |||||||||||
Third Quarter | |||||||||||||
% ∆ as | % ∆ at | ||||||||||||
2020 | 2019 | ||||||||||||
reported | LFL | ||||||||||||
507.9 | 574.4 | -11.6% | -4.6% | ||||||||||
282.3 | 340.9 | -17.2% | -8.5% | ||||||||||
165.3 | 171.9 | -3.8% | +2.7% | ||||||||||
51.3 | 53.2 | -3.6% | -6.7% | ||||||||||
9.1 | 8.4 | +8.0% | +21.0% | ||||||||||
Ontex Babycare revenue decreased 8.5% in Q3 2020 versus the same period last year, due to lower volumes. While market demand in the Babycare category has improved since the summer compared with pandemic- induced pantry loading and subsequent unwinding in our markets, it was below trends observed prior to the impact of COVID-19 which became visible in our markets at the end of Q1. Baby pants outperformed baby diapers in the quarter.
Q3 2020 Adult Incontinence (Adult Inco) revenue increased, up +2.7% year-on-year. Sales of Adult Inco products in retail channels grew by 10%, with both Europe and AMEAA Divisions posting higher revenue. Adult Inco sales in institutional channels were below last year, as COVID-19 impacts resulted in lower demand in hospitals and care homes. Sales of Adult pants were well ahead of overall category growth.
Revenue of Feminine Care products was down 6.7% in Q3 2020 versus prior year. The majority of our Feminine Care sales are in Europe, where market demand was visibly lower than the same period a year ago. Reported revenue was positively impacted by sales to retailer customers in the USA, following completion of the Albaad Feminine Care acquisition on July 1st and subsequent consolidation in our results.
Operational Review: Divisions
Nine Months | |||||||||||||
in € million | 2020 | 2019 | % ∆ as | % ∆ at | |||||||||
reported | LFL | ||||||||||||
Ontex Reported Revenue | 1,561.3 | 1,688.7 | -7.5% | -2.9% | |||||||||
Europe | 651.5 | 707.1 | -7.9% | -6.4% | |||||||||
AMEAA | 582.7 | 647.8 | -10.1% | +0.5% | |||||||||
Healthcare | 327.1 | 333.7 | -2.0% | -1.9% | |||||||||
Third Quarter | ||||||||||||
% ∆ as | % ∆ at | |||||||||||
2020 | 2019 | |||||||||||
reported | LFL | |||||||||||
507.9 | 574.4 | -11.6% | -4.6% | |||||||||
209.5 | 238.0 | -12.0% | -9.8% | |||||||||
189.1 | 225.1 | -16.0% | -0.4% | |||||||||
109.2 | 111.3 | -1.9% | -1.6% | |||||||||
1 2019 revenue in AMEAA and Healthcare has been adjusted due to a shift of customer responsibility between these Divisions effective January 1, 2020, which has no impact on total Ontex revenue. Details can be found in annex.
Europe
Revenue in our Europe Division was down 9.8% in Q3 2020, an improvement on Q2 although below H1 as COVID-19 impacts weighed on market demand. Tracked channel sales decreased in Babycare (down high single digits) and Feminine Care (down mid single digits), with Adult Inco revenue up low single digits, confirming that market demand has not recovered to pre-pandemic levels. Within this demand environment, promotional activity of the leading international branded diaper was reinstated following a brief temporary pause during the demand surge in March and April, and reached unprecedented levels in some major markets in Q3. In addition, the quarter had a net negative balance of contract gains and losses, which will
4
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Ontex Group NV published this content on 04 November 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 November 2020 06:09:09 UTC
